Telangiectatic osteosarcoma

Overview

• Definition: A rare, high-grade variant of osteosarcoma composed of cystic cavities filled with blood and minimal osteoid matrix.
• Epidemiology:
  • Represents ~4% of all osteosarcomas.
  • Age: Same as conventional osteosarcoma (10–25 years).
  • Gender: M > F (slightly).
• Clinical importance: Frequently misdiagnosed as a benign ABC, leading to inappropriate treatment (e.g., curettage instead of wide resection).

Anatomical distribution

• Location: Metaphysis of long bones (distal femur, proximal tibia, proximal humerus).
• Position: Central or eccentric.

Imaging features

Plain radiograph

• Appearance: Purely lytic, destructive lesion.
• Matrix: Minimal to no visible sclerosis/osteoid matrix (unlike conventional osteosarcoma).
• Margins:
  • Geographic bone destruction but with a wide zone of transition.
  • Cortical destruction is common.
  • Periosteal reaction (Codman's triangle, sunburst) may be present but often subtle.
• The Trap: Can look deceptively expansile like an ABC, but the shell is often discontinuous or permeative.

MRI (The problem-solving modality)

• T1: Heterogeneous signal (haemorrhage).
• T2: Fluid-fluid levels are characteristic (present in >90% of cases).
• Post-contrast (Key discriminator):
  • Thick, nodular septations that enhance avidly.
  • Surrounding soft tissue component with enhancement.
  • Differentiation: In ABC, septa are thin and linear; in Telangiectatic OS, septa are thick/nodular and represent viable tumour.

Differential diagnosis: The "deadly mimic"

Management and pathology

• Biopsy rule: Do not perform FNA.
  • Fine needle aspiration often yields only necrotic blood/fluid (non-diagnostic).
  • Core needle biopsy must target the enhancing solid nodular rim or septa to find viable tumour cells.
• Histology: Large blood-filled spaces separated by septa containing highly malignant sarcomatous cells with minimal osteoid production.
• Treatment: Same as conventional osteosarcoma (neoadjuvant chemotherapy $\to$ wide surgical resection $\to$ adjuvant chemotherapy).
• Prognosis: Historically poor due to misdiagnosis, but now similar to conventional osteosarcoma if treated correctly.

High-yield exam pearls